Humacyte, Inc.
HUMA
$0.58
-$0.02-2.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 406.00K | 495.00K | 467.00K | 753.00K | 301.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 406.00K | 495.00K | 467.00K | 753.00K | 301.00K |
| Cost of Revenue | 19.38M | 20.90M | 23.69M | 17.53M | 21.62M |
| Gross Profit | -18.97M | -20.41M | -23.22M | -16.78M | -21.32M |
| SG&A Expenses | 8.03M | 7.83M | 7.62M | 7.61M | 7.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.40M | 28.73M | 31.30M | 25.14M | 29.33M |
| Operating Income | -27.00M | -28.24M | -30.84M | -24.39M | -29.03M |
| Income Before Tax | -36.80M | -17.62M | -24.80M | -17.51M | -37.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.80M | -17.62M | -24.80M | -17.51M | -37.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.80M | -17.62M | -24.80M | -17.51M | -37.66M |
| EBIT | -27.00M | -28.24M | -30.84M | -24.39M | -29.03M |
| EBITDA | -25.21M | -26.45M | -29.05M | -22.53M | -27.17M |
| EPS Basic | -0.16 | -0.09 | -0.13 | -0.11 | -0.24 |
| Normalized Basic EPS | -0.09 | -0.07 | -0.04 | -0.09 | -0.13 |
| EPS Diluted | -0.16 | -0.09 | -0.13 | -0.11 | -0.24 |
| Normalized Diluted EPS | -0.09 | -0.07 | -0.04 | -0.09 | -0.13 |
| Average Basic Shares Outstanding | 234.18M | 197.85M | 186.79M | 158.31M | 155.44M |
| Average Diluted Shares Outstanding | 234.18M | 197.85M | 186.79M | 158.31M | 155.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |